Sfoglia per Autore  INVERNIZZI, PIETRO

Opzioni
Mostrati risultati da 1 a 20 di 313
Titolo Tipologia Data di pubblicazione Autori File
Advancements in pharmacological treatment of NAFLD/MASLD: a focus on metabolic and liver-targeted interventions 01 - Articolo su rivista 2024 Ciardullo, SVergani, MInvernizzi, PPerseghin, G +
Impact of MASLD and MetALD on clinical outcomes: A meta-analysis of preliminary evidence 01 - Articolo su rivista 2024 Ciardullo, SInvernizzi, PPerseghin, G +
Improving predictive accuracy in primary biliary cholangitis: A new genetic risk score 01 - Articolo su rivista 2024 Gerussi A.Bernasconi D. P.Cristoferi L.Valsecchi M. G.Carbone M.Invernizzi P. +
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain? 01 - Articolo su rivista 2024 Carbone M.Invernizzi P.Cristoferi L. +
Eosinophilic esophagitis: does age matter? 01 - Articolo su rivista 2024 Massironi S.Mulinacci G.Biondi A.Invernizzi P. +
Paradoxical association between dyspepsia and autoimmune chronic atrophic gastritis: Insights into mechanisms, pathophysiology, and treatment options 01 - Articolo su rivista 2023 Invernizzi P.Massironi S. +
Authors' reply to Zou et al 01 - Articolo su rivista 2023 Ciardullo, StefanoCarbone, MarcoInvernizzi, PietroPerseghin, Gianluca
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study 01 - Articolo su rivista 2023 Invernizzi P. +
Exploring the spectrum of incidental gastric polyps in autoimmune gastritis 01 - Articolo su rivista 2023 Massironi S.Gallo C.Laffusa A.Invernizzi P. +
Corrigendum to: “Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆” [J Hepatol (2020) 505–515, (S0168827820302130), (10.1016/j.jhep.2020.04.003)] 99 - Altro 2023 Invernizzi P. +
Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort 01 - Articolo su rivista 2023 Puoti M.Invernizzi P. +
Incidence and prevalence of gastric neuroendocrine tumors in patients with chronic atrophic autoimmune gastritis 01 - Articolo su rivista 2023 Massironi S.Gallo C.Stegagnini M.Invernizzi P. +
Risk stratification in primary sclerosing cholangitis 01 - Articolo su rivista 2023 Cristoferi, LauraLucà, MartinaGerussi, AlessioInvernizzi, PietroCarbone, Marco +
A second update on mapping the human genetic architecture of COVID-19 01 - Articolo su rivista 2023 Invernizzi, PietroGerussi, AlessioBiondi, AndreaBellani, GiacomoBellelli, GiuseppeCiterio, GiuseppeFoti, GiuseppeBettini, Laura RacheleValsecchi, Maria G.Cazzaniga, MarinaFaverio, PaolaBonfanti, Paolo +
Noninvasive identification of probable fibrotic nonalcoholic steatohepatitis across the spectrum of glucose tolerance in the United States 01 - Articolo su rivista 2023 Ciardullo, StefanoCarbone, MarcoInvernizzi, PietroPerseghin, Gianluca
Autoimmune liver diseases 01 - Articolo su rivista 2023 Scaravaglio M.Carbone M.Invernizzi P.
Artificial Intelligence and liver: Opportunities and barriers 01 - Articolo su rivista 2023 Gerussi A.Invernizzi P.Carbone M.Cabitza F. +
Prevalence and significance of antimitochondrial antibodies in autoimmune hepatitis (AIH): Results from a large multicentre study of the International AIH Group 01 - Articolo su rivista 2023 Invernizzi P. +
Impact of metformin on the incidence of human cholangiocarcinoma in diabetic patients: A systematic review and meta-analysis 01 - Articolo su rivista 2023 Laffusa A.Ciaccio A.Gallo C.Invernizzi P.Massironi S. +
Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival 01 - Articolo su rivista 2023 Carbone M.Invernizzi P. +
Mostrati risultati da 1 a 20 di 313
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile